JG
ARNA

Joel Greenblatt’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Joel Greenblatt’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,122
Closed -$1.12M – 1261
2019
Q2 		$1.12M Buy
+19,122
New +$988K 0.02% 609
2018
Q2 		– Sell
-5,406
Closed -$214K – 1097
2018
Q1 		$214K Buy
+5,406
New +$210K ﹤0.01% 880
2017
Q2 		– Sell
-3,780
Closed -$55K – 1125
2017
Q1 		$55K Buy
+3,780
New +$56K ﹤0.01% 963

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Joel Greenblatt's ARNA Position: Q3 2019 in Review

Joel Greenblatt sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 19,122 shares — an estimated $1.12M sold.

Joel Greenblatt first reported a position in ARNA in Q1 2017 and held it in 3 quarters. The position peaked at $1.12M in Q2 2019. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

  • Joel Greenblatt reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
  • Joel Greenblatt sold 19,122 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $1.12M.
  • Joel Greenblatt first reported a position in Arena Pharmaceuticals Inc in Q1 2017 and held it in 3 quarters.
  • Joel Greenblatt's Arena Pharmaceuticals Inc position peaked at $1.12M in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Gotham Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.